• Revenue Cycle Management
  • COVID-19
  • Reimbursement
  • Diabetes Awareness Month
  • Risk Management
  • Patient Retention
  • Staffing
  • Medical Economics® 100th Anniversary
  • Coding and documentation
  • Business of Endocrinology
  • Telehealth
  • Physicians Financial News
  • Cybersecurity
  • Cardiovascular Clinical Consult
  • Locum Tenens, brought to you by LocumLife®
  • Weight Management
  • Business of Women's Health
  • Practice Efficiency
  • Finance and Wealth
  • EHRs
  • Remote Patient Monitoring
  • Sponsored Webinars
  • Medical Technology
  • Billing and collections
  • Acute Pain Management
  • Exclusive Content
  • Value-based Care
  • Business of Pediatrics
  • Concierge Medicine 2.0 by Castle Connolly Private Health Partners
  • Practice Growth
  • Concierge Medicine
  • Business of Cardiology
  • Implementing the Topcon Ocular Telehealth Platform
  • Malpractice
  • Influenza
  • Sexual Health
  • Chronic Conditions
  • Technology
  • Legal and Policy
  • Money
  • Opinion
  • Vaccines
  • Practice Management
  • Patient Relations
  • Careers

Trauma care price review; misusing telehealth patient data; inspirations for medicines – Morning Medical Update


The top news stories in medicine today.

Doctor morning desk: © Alena Kryazheva – stock.adobe.com

© Alena Kryazheva – stock.adobe.com

Trauma care costs

The 2021 Hospital Price Transparency Rule mandated hospitals to disclose prices in hopes of allowing good decision-making when selecting health care. Researchers reviewed trauma activation fees and found wide, “substantial, and often irrational, variations” across hospitals and states, “suggesting that price variations cannot be explained by trauma severity alone." Read more in JAMA Surgery.

Telehealth violation

The Federal Trade Commission announced telehealth company Cerebral Inc. will pay $7 million for disclosing consumers’ sensitive personal health information to third parties for advertising. The Commission “is ordering a first-of-its-kind prohibition” barring Cerebral from using any health information for most marketing purposes.

Good for what ails patients

What do garlic, marijuana, medieval weaponry and virtual livers have in common? All are seemingly unlikely inspirations for new medicines, according to a news release by the American Chemical Society.

Related Videos